Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 mild to moderate meta-analysis

COL-COVID (Pascual-Figal)
 
NCT04350320
RCTcolchicinestandard of careCOVID-19 mild to moderatesome concern
52/51 inconclusive
    Rashad (CLARI vs SoC) RCTclarithromycinestandard of careCOVID-19 mild to moderatesome concern
    99/99 suggested
    • suggested 1.9-fold increase in radiologic improvement (14-day) with a moderate degree of certainty due to some concern in risk of bias

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).